SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-241045
Filing Date
2018-08-07
Accepted
2018-08-07 16:03:07
Documents
4
Period of Report
2018-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d562834d8k.htm 8-K 15842
2 EXHIBIT 10.1 d562834dex101.htm EX-10.1 44161
3 GRAPHIC g562834snap3.jpg GRAPHIC 4471
4 GRAPHIC g562834snap4.jpg GRAPHIC 61051
  Complete submission text file 0001193125-18-241045.txt   151467
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 18997911
SIC: 2834 Pharmaceutical Preparations